$RKDA
Arcadia Biosciences, Inc.

2018 Q4 Form 10-K Financial Statement

#000156459019010452 Filed on April 01, 2019

View on sec.gov

Income Statement

Concept 2018 Q4 2017 Q4 2017
Revenue $440.0K $1.430M $4.026M
YoY Change -69.23% 164.81% 26.29%
Cost Of Revenue $230.0K $20.00K $283.0K
YoY Change 1050.0% -96.92% -68.38%
Gross Profit $210.0K $1.410M $3.743M
YoY Change -85.11% -1381.82% 63.24%
Gross Profit Margin 47.73% 98.6% 92.97%
Selling, General & Admin $3.020M $2.240M $10.65M
YoY Change 34.82% -33.53% -13.05%
% of Gross Profit 1438.1% 158.87% 284.56%
Research & Development $1.550M $2.170M $7.407M
YoY Change -28.57% 9.05% -14.5%
% of Gross Profit 738.1% 153.9% 197.89%
Depreciation & Amortization $30.00K $60.00K $279.0K
YoY Change -50.0% -14.29% -7.0%
% of Gross Profit 14.29% 4.26% 7.45%
Operating Expenses $4.570M $4.410M $18.34M
YoY Change 3.63% -17.72% -15.9%
Operating Profit -$4.360M -$3.000M -$14.32M
YoY Change 45.33% -45.16% -23.12%
Interest Expense $3.580M $0.00 $747.0K
YoY Change -100.0% -43.37%
% of Operating Profit
Other Income/Expense, Net $120.0K $40.00K $281.0K
YoY Change 200.0% -60.0% -17.35%
Pretax Income -$660.0K -$2.970M -$15.68M
YoY Change -77.78% -47.99% -19.99%
Income Tax -$20.00K -$10.00K $26.00K
% Of Pretax Income
Net Earnings -$650.0K -$2.960M -$15.71M
YoY Change -78.04% -48.16% -19.96%
Net Earnings / Revenue -147.73% -206.99% -390.14%
Basic Earnings Per Share
Diluted Earnings Per Share -$136.0K -$1.390M -$7.273M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2017 Q4 2017
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.82M $13.02M $13.02M
YoY Change 67.59% -74.25% -74.25%
Cash & Equivalents $12.00M $9.125M $9.130M
Short-Term Investments $9.830M $3.900M $3.900M
Other Short-Term Assets $700.0K $560.0K $560.0K
YoY Change 25.0% -36.36% -36.36%
Inventory $181.0K $229.0K $230.0K
Prepaid Expenses
Receivables $165.0K $1.231M $1.240M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $22.88M $15.05M $15.05M
YoY Change 52.03% -71.19% -71.18%
LONG-TERM ASSETS
Property, Plant & Equipment $395.0K $299.0K $300.0K
YoY Change 32.11% -41.37% -41.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $7.000K $56.00K $1.220M
YoY Change -87.5% 194.74% -9.63%
Total Long-Term Assets $1.148M $1.523M $1.520M
YoY Change -24.62% -65.02% -65.06%
TOTAL ASSETS
Total Short-Term Assets $22.88M $15.05M $15.05M
Total Long-Term Assets $1.148M $1.523M $1.520M
Total Assets $24.02M $16.57M $16.57M
YoY Change 44.98% -70.71% -70.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.00K $30.00K $30.00K
YoY Change 0.0% 0.0% -88.0%
Accrued Expenses
YoY Change
Deferred Revenue $96.00K $1.000M
YoY Change -90.4%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $3.054M $3.525M $3.530M
YoY Change -13.36% 12.62% 12.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $3.072M $3.000M $5.040M
YoY Change 2.4% 0.0% -17.65%
Total Long-Term Liabilities $3.072M $3.000M $5.040M
YoY Change 2.4% -89.33% -83.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.054M $3.525M $3.530M
Total Long-Term Liabilities $3.072M $3.000M $5.040M
Total Liabilities $11.21M $8.563M $8.560M
YoY Change 30.9% -75.09% -75.1%
SHAREHOLDERS EQUITY
Retained Earnings -$178.4M -$167.3M
YoY Change 6.64% 10.36%
Common Stock $191.2M $175.3M
YoY Change 9.08% 0.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.82M $8.007M $8.010M
YoY Change
Total Liabilities & Shareholders Equity $24.02M $16.57M $16.57M
YoY Change 44.98% -70.71% -70.71%

Cashflow Statement

Concept 2018 Q4 2017 Q4 2017
OPERATING ACTIVITIES
Net Income -$650.0K -$2.960M -$15.71M
YoY Change -78.04% -48.16% -19.96%
Depreciation, Depletion And Amortization $30.00K $60.00K $279.0K
YoY Change -50.0% -14.29% -7.0%
Cash From Operating Activities -$2.690M -$2.690M -$13.97M
YoY Change 0.0% -37.15% -18.14%
INVESTING ACTIVITIES
Capital Expenditures -$160.0K $0.00 $79.00K
YoY Change -100.0% -65.8%
Acquisitions
YoY Change
Other Investing Activities $8.180M $8.880M $47.26M
YoY Change -7.88% -311.93% -1032.15%
Cash From Investing Activities $8.020M $8.880M $47.18M
YoY Change -9.68% -311.43% -990.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 -26.10M
YoY Change -100.0% -6625.25%
NET CHANGE
Cash From Operating Activities -2.690M -2.690M -13.97M
Cash From Investing Activities 8.020M 8.880M 47.18M
Cash From Financing Activities 0.000 0.000 -26.10M
Net Change In Cash 5.330M 6.190M 7.112M
YoY Change -13.89% -173.17% -132.39%
FREE CASH FLOW
Cash From Operating Activities -$2.690M -$2.690M -$13.97M
Capital Expenditures -$160.0K $0.00 $79.00K
Free Cash Flow -$2.530M -$2.690M -$14.04M
YoY Change -5.95% -37.0% -18.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4774919
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4774919
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1464000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4026000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6069000
CY2018 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4777419
CY2018Q2 dei Entity Public Float
EntityPublicFloat
39400000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11998000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9125000
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
9825000
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
3898000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
165000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1231000
CY2018Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3000
CY2017Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
4000
CY2018Q4 us-gaap Inventory Net
InventoryNet
181000
CY2017Q4 us-gaap Inventory Net
InventoryNet
229000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
704000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
560000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
22876000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
15047000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
395000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
299000
CY2018Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
746000
CY2017Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
1168000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
96000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1000000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
284000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3054000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3525000
CY2017Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2038000
CY2018Q4 rkda Common Stock Warrant Liabilities
CommonStockWarrantLiabilities
5083000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
12815000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24024000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
176000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
87000
CY2018 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-1000
CY2017 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-1000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-312000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-822000
CY2018 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
25000
CY2018 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
72000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-16870000
CY2017 us-gaap Interest Expense
InterestExpense
747000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
281000
CY2018 rkda Initial Loss On Common Stock Warrant And Common Stock Adjustment Feature Liabilities
InitialLossOnCommonStockWarrantAndCommonStockAdjustmentFeatureLiabilities
4000000
CY2017 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-2000
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
98000
CY2018 us-gaap Inventory Write Down
InventoryWriteDown
310000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1066000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
882000
CY2018 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-2000
CY2017 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-179000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-160000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11604000
CY2018 us-gaap Operating Expenses
OperatingExpenses
18334000
CY2018 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9561000
CY2018 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
2555000
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-900000
CY2018 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-13470000
CY2017 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-15681000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-15707000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.58
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.28
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3766419
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2156201
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
18000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
18000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13480000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15689000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
22198000
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
24000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1474000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
18000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
963000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6000
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
526000
CY2018 rkda Adjustments To Additional Paid In Capital Reclassification Of Common Stock Adjustment Feature Liability To Equity
AdjustmentsToAdditionalPaidInCapitalReclassificationOfCommonStockAdjustmentFeatureLiabilityToEquity
8378000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1550000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000
CY2018 us-gaap Depreciation
Depreciation
154000
CY2017 us-gaap Depreciation
Depreciation
279000
CY2018 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3000
CY2017 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1000
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
193000
CY2017 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
89000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1550000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1474000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-183000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
151000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-324000
CY2017 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-11000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13631000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13965000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
250000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
79000
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
29885000
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
19405000
CY2018 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
24150000
CY2017 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
66658000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5975000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
47178000
CY2018 rkda Proceeds From Issuance Of Common Stock And Warrants From Purchase Agreement
ProceedsFromIssuanceOfCommonStockAndWarrantsFromPurchaseAgreement
10000000
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1308000
CY2018 rkda Proceeds From Issuance Of Common Stock And Warrants From Offering
ProceedsFromIssuanceOfCommonStockAndWarrantsFromOffering
14000000
CY2018 rkda Payments Of Offering Costs
PaymentsOfOfferingCosts
1182000
CY2017 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
1125000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
969000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
24000
CY2017 rkda Payment On Notes Payable
PaymentOnNotesPayable
25000000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22479000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26101000
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2873000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7112000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2013000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
746000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
34000
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
2000
CY2018 rkda Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses
OfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses
23000
CY2017 rkda Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses
OfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses
50000
CY2018 rkda Warrant Issued Included In Offering Costs
WarrantIssuedIncludedInOfferingCosts
526000
CY2018 rkda Warrants Issued Charged Against Equity
WarrantsIssuedChargedAgainstEquity
239000
CY2017 rkda Proceeds From Sale Of Fixed Assets Included In Prepaid Expenses And Other Current Assets
ProceedsFromSaleOfFixedAssetsIncludedInPrepaidExpensesAndOtherCurrentAssets
7000
CY2018 rkda Reclassification Of Unearned Revenue To Other Short Term Liabilities
ReclassificationOfUnearnedRevenueToOtherShortTermLiabilities
259000
CY2018 rkda Adjustments To Additional Paid In Capital Reclassification Of Common Stock Warrant To Liability
AdjustmentsToAdditionalPaidInCapitalReclassificationOfCommonStockWarrantToLiability
8378000
CY2017 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
2000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions in the Company&#8217;s consolidated financial statements and notes thereto. Significant estimates and assumptions made by management included the determination of the provision for income taxes, stock-based compensation, fair value of certain equity instruments, costs to complete government grants and research contracts, and net realizable value of inventory. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents are maintained with several financial institutions. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions with reputable credit and therefore bear minimal credit risk. The Company seeks to mitigate its credit risks by spreading such risks across multiple counterparties and monitoring the risk profiles of these counterparties.</p>
CY2018 rkda Entity Incorporation Year Of Incorporation
EntityIncorporationYearOfIncorporation
2002
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
12841000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2018 us-gaap Variable Interest Entity Terms Of Arrangements
VariableInterestEntityTermsOfArrangements
Both the Company and Bioceres incur expenses in support of specific activities agreed, as defined by joint work plans, which apply fair market value to each partner’s activities. Unequal contributions of services are equalized by the partners through cash payments. Verdeca is not the primary obligor for these activities performed by the Company or Bioceres. An agreement executed in conjunction with the formation of Verdeca specified that if Bioceres determines it requires cash to fund its contributed services (subject to certain annual limits), Bioceres, S.A. may elect to sell shares of its common stock to the Company for an amount not exceeding $5.0
CY2018 rkda Contributed Services Period
ContributedServicesPeriod
P4Y
CY2018 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
947000
CY2018 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Arizona
CY2018 rkda Entity Reincorporation State Country Name
EntityReincorporationStateCountryName
Delaware
CY2018 rkda Entity Reincorporation Date Of Reincorporation
EntityReincorporationDateOfReincorporation
2015-03
CY2018 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:20
CY2018 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2018Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
41000
CY2017Q4 rkda Inventory Raw Materials Current And Non Current
InventoryRawMaterialsCurrentAndNonCurrent
45000
CY2018Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
886000
CY2017Q4 rkda Inventory Finished Goods Current And Non Current
InventoryFinishedGoodsCurrentAndNonCurrent
1352000
CY2018Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
927000
CY2017Q4 rkda Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
1397000
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5196000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5180000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4801000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4881000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
154000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
279000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
21072000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
21072000
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
12842000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2018Q4 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
0
CY2018Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
21072000
CY2017Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
12841000
CY2017 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
912000
CY2018Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
285000
CY2017Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
366000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1096000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
805000
CY2018Q4 rkda Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
433000
CY2017Q4 rkda Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
899000
CY2018Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
187000
CY2017Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
177000
CY2018Q4 rkda Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
92000
CY2017Q4 rkda Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
32000
CY2018Q4 rkda Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
91000
CY2017Q4 rkda Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
51000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
285000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
83000
CY2018Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
0
CY2017Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
24000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
176000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
59000
CY2016 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
23
CY2017 us-gaap Other Restructuring Costs
OtherRestructuringCosts
0
CY2018 us-gaap Other Restructuring Costs
OtherRestructuringCosts
0
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
0
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
0
CY2018 rkda Period Of Trading Days Taken For Calculation Of Volume Weighted Average Price
PeriodOfTradingDaysTakenForCalculationOfVolumeWeightedAveragePrice
P3D
CY2018 rkda Percentage Of Volume Weighted Average Price Of Common Stock
PercentageOfVolumeWeightedAveragePriceOfCommonStock
0.80
CY2018 rkda Percentage Of Volume Weighted Average Price Of Warrant
PercentageOfVolumeWeightedAveragePriceOfWarrant
1.10
CY2018Q4 us-gaap Share Price
SharePrice
32.52
CY2018Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2018 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
4000000
CY2018 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10000000
CY2018 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
50000000
CY2018Q4 rkda Fair Value Of Common Stock Warrants At Inception
FairValueOfCommonStockWarrantsAtInception
9000000
CY2018Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
197000
CY2018 rkda Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
228939
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
111336
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
24334
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
27812
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
288129
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
302077
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44354
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4006
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
11802
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
530044
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
519655
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
183300
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
87.60
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.20
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
31.75
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
98.95
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
63.62
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.65
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
21.73
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.21
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
43.73
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.53
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
35.91
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
71.47
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1300000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
449000
CY2018Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1200000
CY2018 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.65
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.20
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2822903
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
18.37
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
330.40
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
704000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
713000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
595000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
497000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
295000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2804000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1300000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1200000
CY2018Q4 rkda Royalties On Licensed Revenue Accrued
RoyaltiesOnLicensedRevenueAccrued
216000
CY2017Q4 rkda Royalties On Licensed Revenue Accrued
RoyaltiesOnLicensedRevenueAccrued
206000
CY2018 rkda Milestones Payments Yet To Be Achieved
MilestonesPaymentsYetToBeAchieved
2000000
CY2017 rkda Milestones Payments Yet To Be Achieved
MilestonesPaymentsYetToBeAchieved
2000000
CY2018 rkda Milestones Payment
MilestonesPayment
0
CY2017 rkda Milestones Payment
MilestonesPayment
0
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-13470000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-15681000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13470000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15681000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
9000
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
24000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
26000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.085
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.026
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.273
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.914
CY2018 rkda Effective Income Tax Rate Reconciliation Transaction Costs Percentage
EffectiveIncomeTaxRateReconciliationTransactionCostsPercentage
-0.029
CY2017 rkda Effective Income Tax Rate Reconciliation Transaction Costs Percentage
EffectiveIncomeTaxRateReconciliationTransactionCostsPercentage
0.00
CY2018 rkda Effective Income Tax Rate Reconciliation Related Offering Costs Percentage
EffectiveIncomeTaxRateReconciliationRelatedOfferingCostsPercentage
-0.011
CY2017 rkda Effective Income Tax Rate Reconciliation Related Offering Costs Percentage
EffectiveIncomeTaxRateReconciliationRelatedOfferingCostsPercentage
0.00
CY2018 rkda Effective Income Tax Rate Reconciliation Excess Windfall Benefit Percentage
EffectiveIncomeTaxRateReconciliationExcessWindfallBenefitPercentage
0.014
CY2017 rkda Effective Income Tax Rate Reconciliation Excess Windfall Benefit Percentage
EffectiveIncomeTaxRateReconciliationExcessWindfallBenefitPercentage
0.00
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.00
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.001
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.00
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-1.246
CY2018 rkda Effective Income Tax Rate Reconciliation Withholding Taxes
EffectiveIncomeTaxRateReconciliationWithholdingTaxes
-0.001
CY2017 rkda Effective Income Tax Rate Reconciliation Withholding Taxes
EffectiveIncomeTaxRateReconciliationWithholdingTaxes
-0.002
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.004
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.035
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
42097000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
37498000
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
26000
CY2017Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
783000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2855000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2273000
CY2018Q4 rkda Deferred Tax Assets Accrued Payroll And Benefits
DeferredTaxAssetsAccruedPayrollAndBenefits
255000
CY2017Q4 rkda Deferred Tax Assets Accrued Payroll And Benefits
DeferredTaxAssetsAccruedPayrollAndBenefits
51000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
171000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
171000
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
114000
CY2017Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
128000
CY2018Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
508000
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
396000
CY2018Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
3000
CY2017Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
3000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
46029000
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
41303000
CY2018Q4 rkda Deferred Tax Liabilities Common Stock Warrant Liabilities
DeferredTaxLiabilitiesCommonStockWarrantLiabilities
1529000
CY2017Q4 rkda Deferred Tax Liabilities Common Stock Warrant Liabilities
DeferredTaxLiabilitiesCommonStockWarrantLiabilities
0
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1529000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
44500000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41303000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-3200000
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
14300000
CY2018 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
it has not forfeited the right to carryforward tax losses up to 20 years
CY2018 rkda Income Tax Examination Year Subject Under Examination
IncomeTaxExaminationYearSubjectUnderExamination
2000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2018 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.03
CY2018 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
Employees’ rights to employer contributions vest on the one-year anniversary of their date of employment.
CY2018 rkda Defined Benefit Plan Contribution Vesting Period
DefinedBenefitPlanContributionVestingPeriod
P1Y
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3352947
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
354974

Files In Submission

Name View Source Status
0001564590-19-010452-index-headers.html Edgar Link pending
0001564590-19-010452-index.html Edgar Link pending
0001564590-19-010452.txt Edgar Link pending
0001564590-19-010452-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gyddj0mjzjo5000001.jpg Edgar Link pending
gyddj0mjzjo5000002.jpg Edgar Link pending
gyddj0mjzjo5000003.jpg Edgar Link pending
gyddj0mjzjo5000004.jpg Edgar Link pending
gyddj0mjzjo5000005.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rkda-10k_20181231.htm Edgar Link pending
rkda-20181231.xml Edgar Link completed
rkda-20181231.xsd Edgar Link pending
rkda-20181231_cal.xml Edgar Link unprocessable
rkda-20181231_def.xml Edgar Link unprocessable
rkda-20181231_lab.xml Edgar Link unprocessable
rkda-20181231_pre.xml Edgar Link unprocessable
rkda-ex311_6.htm Edgar Link pending
rkda-ex312_7.htm Edgar Link pending
rkda-ex321_9.htm Edgar Link pending
rkda-ex322_8.htm Edgar Link pending
Show.js Edgar Link pending